THEMIS study of Brilinta in patients with CAD and type 2 diabetes meets primary endpoint Feb. 25, 2019
New phase I study explores use of cardiac troponin activator AMG-594 in healthy subjects Feb. 21, 2019
New PAI-1 inhibitors presented by Eastern Michigan University and the University of Michigan Feb. 15, 2019
RSS